Blood & Cancer

How do patients fare when they have cancer and COVID-19? Researchers developed the COVID-19 and Cancer Consortium (CCC19) and the National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS) to gain some insight. In this episode, Brian Rini, MD, a professor of medicine at Vanderbilt University Medical Center, Nashville, Tenn., and host of The Uromigos podcast, explains what CCC19 and NCCAPS are. He also discusses findings from CCC19 that were presented at the European Society of Medical Oncology Virtual Congress 2020. NCCAPS (NCT04387656) NCCAPS is a natural history study of COVID-19 in patients with active cancer. It is a prospective study, funded by the National Cancer Institute, that is open at more than 500 centers. The study is open to U.S. adults who are receiving active cancer treatment and either have COVID-19 or are awaiting a SARS-CoV-2 test result. Researchers collect blood samples and other data from patients enrolled. Blood is collected at baseline and at regular intervals incorporated